|
DYNAVAX TECHNOLOGIES CORPORATION : Dynavax Initiates First Human …
4-traders (press release) BERKELEY, CA — (Marketwired) — 10/09/13 — Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the start of dosing in the first human clinical trial in its asthma program. Dynavax is conducting the trial under its collaboration agreement … Dynavax starts Phase I trial of asthma treatment Dynavax Initiates First Human Trial in Asthma Program |
View full post on asthma – Google News